{
  "retracted": false,
  "timestamp": 1535155200000,
  "updates": [
    {
      "timestamp": 1574859406256,
      "identifier": {
        "doi": "10.1016/j.ijpharm.2018.06.045"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ijpharm.2017.10.029"
  },
  "journal": "International Journal of Pharmaceutics",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1–34 for the treatment of osteoporosis” [Int. J. Pharm. 535 (2018) 113–119]"
}
